Current and historical daily PE Ratio for Hanall Biopharma Co Ltd (
XKRX:009420
) from 1990 to May 14 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hanall Biopharma stock (XKRX:009420) PE ratio as of May 14 2024 is 493.38.
More Details
Hanall Biopharma Co Ltd (XKRX:009420) PE Ratio (TTM) Chart
Hanall Biopharma Co Ltd (XKRX:009420) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1252
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Hanall Biopharma PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-14 | 516.9 | 2024-03-07 | 525.7 |
| 2024-05-13 | 493.4 | 2024-03-06 | 524.3 |
| 2024-05-10 | 499.3 | 2024-03-05 | 516.9 |
| 2024-05-09 | 502.9 | 2024-03-04 | 513.2 |
| 2024-05-08 | 513.2 | 2024-02-29 | 511.8 |
| 2024-05-07 | 527.2 | 2024-02-28 | 530.1 |
| 2024-05-03 | 518.4 | 2024-02-27 | 510.3 |
| 2024-05-02 | 524.3 | 2024-02-26 | 546.3 |
| 2024-04-30 | 530.9 | 2024-02-23 | 539.0 |
| 2024-04-29 | 519.9 | 2024-02-22 | 533.8 |
| 2024-04-26 | 511.0 | 2024-02-21 | 531.6 |
| 2024-04-25 | 506.6 | 2024-02-20 | 519.9 |
| 2024-04-24 | 519.1 | 2024-02-19 | 522.1 |
| 2024-04-23 | 518.4 | 2024-02-16 | 511.8 |
| 2024-04-22 | 509.6 | 2024-02-15 | 521.3 |
| 2024-04-19 | 472.1 | 2024-02-14 | 514.0 |
| 2024-04-18 | 489.7 | 2024-02-13 | 517.6 |
| 2024-04-17 | 469.1 | 2024-02-08 | 477.9 |
| 2024-04-16 | 482.4 | 2024-02-07 | 477.9 |
| 2024-04-15 | 483.8 | 2024-02-06 | 486.8 |
| 2024-04-12 | 502.9 | 2024-02-05 | 441.2 |
| 2024-04-11 | 467.6 | 2024-02-02 | 441.9 |
| 2024-04-09 | 475.0 | 2024-02-01 | 425.0 |
| 2024-04-08 | 472.8 | 2024-01-31 | 453.7 |
| 2024-04-05 | 485.3 | 2024-01-30 | 481.6 |
| 2024-04-04 | 500.0 | 2024-01-29 | 483.1 |
| 2024-04-03 | 500.0 | 2024-01-26 | 510.3 |
| 2024-04-02 | 526.5 | 2024-01-25 | 494.9 |
| 2024-04-01 | 563.2 | 2024-01-24 | 491.2 |
| 2024-03-29 | 550.0 | 2024-01-23 | 500.0 |
| 2024-03-28 | 559.6 | 2024-01-22 | 505.9 |
| 2024-03-27 | 568.4 | 2024-01-19 | 506.6 |
| 2024-03-26 | 592.6 | 2024-01-18 | 525.7 |
| 2024-03-25 | 596.3 | 2024-01-17 | 530.9 |
| 2024-03-22 | 560.3 | 2024-01-16 | 549.3 |
| 2024-03-21 | 562.5 | 2024-01-15 | 559.6 |
| 2024-03-20 | 536.8 | 2024-01-12 | 575.7 |
| 2024-03-19 | 552.9 | 2024-01-11 | 584.6 |
| 2024-03-18 | 548.5 | 2024-01-10 | 589.7 |
| 2024-03-15 | 529.4 | 2024-01-09 | 581.6 |
| 2024-03-14 | 566.9 | 2024-01-08 | 576.5 |
| 2024-03-13 | 575.7 | 2024-01-05 | 576.5 |
| 2024-03-12 | 572.8 | 2024-01-04 | 591.9 |
| 2024-03-11 | 577.9 | 2024-01-03 | 620.6 |
| 2024-03-08 | 567.6 | 2024-01-02 | 635.3 |
Hanall Biopharma Co Ltd (XKRX:009420) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Hanall Biopharma Co Ltd
SIC : 111
ISIN : KR7009420001
Compare
Compare
Traded in other countries / regions
009420.Korea IPO Date
1989-12-18Description
Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers